Abdelwahab tested positive for values consistent with the administration of testosterone of exogenous origin in a urine sample collected by Drug Free Sport International (DFSI), the biological sample collection and shipping agency of the UFC’s ADP, on March 23, 2024. Prior to Abdelwahab being notified of this adverse finding, another sample that he provided to DFSI on May 3, 2024, also tested positive for values consistent with the administration of testosterone of exogenous origin. Because Abdelwahab had not yet been notified by CSAD of the first adverse finding, the second adverse finding is not being treated as a separate violation under the UFC ADP.
Statement On Hamdy Abdelwahab
